Federal Register of Legislation - Australian Government

Primary content

PB 50 of 2023 Determinations/Health as made
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) to increase existing brand premiums for specified drugs, implement a new brand premium for one pharmaceutical item, remove one brand premium from one pharmaceutical item, and remove three pharmaceutical items with brand premiums that are delisting from the Pharmaceutical Benefits Scheme on 1 June 2023.
Administered by: Health and Aged Care
Registered 31 May 2023
Tabling HistoryDate
Tabled HR13-Jun-2023
Tabled Senate13-Jun-2023
Date of repeal 05 Sep 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 50 of 2023

 

National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 4)

I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated        30 May 2023

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

 


1  Name

                   This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 4).

                   This instrument may also be cited as PB 50 of 2023.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 June 2023

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

 

1.            Schedule 1 - entry for Allopurinol

Omit

Allopurinol

Tablet 100 mg

Oral

Zyloprim

200

4.52

8.91

 

Tablet 300 mg

Oral

Zyloprim

60

3.50

7.91

 

Insert

Allopurinol

Tablet 100 mg

Oral

Zyloprim

200

4.52

9.75

 

Tablet 300 mg

Oral

Zyloprim

60

3.50

 8.74

 

 

2.            Schedule 1 - entry for Amlodipine with valsartan

Omit

Amlodipine with valsartan

Tablet 5 mg (as besilate)-80 mg

Oral

Exforge 5/80

28

7.42

10.21

 

Tablet 5 mg (as besilate)-160 mg

Oral

Exforge 5/160

28

9.31

12.10

 

Tablet 5 mg (as besilate)-320 mg

Oral

Exforge 5/320

28

11.72

14.51

 

Tablet 10 mg (as besilate)-160 mg

Oral

Exforge 10/160

28

9.80

12.56

 

Tablet 10 mg (as besilate)-320 mg

Oral

Exforge 10/320

28

11.91

14.61

Insert

Amlodipine with valsartan

Tablet 5 mg (as besilate)-80 mg

Oral

Exforge 5/80

28

7.42

11.14

 

Tablet 5 mg (as besilate)-160 mg

Oral

Exforge 5/160

28

9.31

13.03

 

Tablet 5 mg (as besilate)-320 mg

Oral

Exforge 5/320

28

11.72

15.44

 

Tablet 10 mg (as besilate)-160 mg

Oral

Exforge 10/160

28

9.80

13.52

 

Tablet 10 mg (as besilate)-320 mg

Oral

Exforge 10/320

28

11.91

15.63

 

 

3.            Schedule 1 - entry for Amlodipine with valsartan and hydrochlorothiazide

Omit

Amlodipine with valsartan and hydrochlorothiazide

Tablet 5 mg (as besilate)-160 mg-12.5 mg

Oral

Exforge HCT 5/160/12.5

28

10.72

13.51

 

Tablet 5 mg (as besilate)-160 mg-25 mg

Oral

Exforge HCT 5/160/25

28

12.13

  14.92

 

Tablet 10 mg (as besilate)-160 mg-12.5 mg

Oral

Exforge HCT 10/160/12.5

28

11.21

                13.97

 

Tablet 10 mg (as besilate)-160 mg-25 mg

Oral

Exforge HCT 10/160/25

28

12.62

                15.39

 

Tablet 10 mg (as besilate)-320 mg-25 mg

Oral

Exforge HCT 10/320/25

28

14.73

                17.44

 

Insert

Amlodipine with valsartan and hydrochlorothiazide

Tablet 5 mg (as besilate)-160 mg-12.5 mg

Oral

Exforge HCT 5/160/12.5

28

10.72

20.02

 

Tablet 5 mg (as besilate)-160 mg-25 mg

Oral

Exforge HCT 5/160/25

28

12.13

15.85

 

Tablet 10 mg (as besilate)-160 mg-12.5 mg

Oral

Exforge HCT 10/160/12.5

28

11.21

14.93

 

Tablet 10 mg (as besilate)-160 mg-25 mg

Oral

Exforge HCT 10/160/25

28

12.62

21.92

 

Tablet 10 mg (as besilate)-320 mg-25 mg

Oral

Exforge HCT 10/320/25

28

14.73

18.45

 

 

4.            Schedule 1 - entry for Betamethasone

 

Omit

Betamethasone

Cream 200 micrograms (as valerate) per g, 100 g

Application

Betnovate 1/5

1

4.93

6.84

 

Application

Celestone-M

1

4.93

6.52

 

Cream 500 micrograms (as dipropionate) per
g, 15 g

Application

Diprosone

1

3.65

5.18

 

Cream 500 micrograms (as valerate) per g, 15 g

Application

Betnovate 1/2

1

2.50

4.88

 

Ointment 500 micrograms (as dipropionate) per g, 15 g

Application

Diprosone

1

3.65

5.18

 

Insert

Betamethasone

Cream 200 micrograms (as valerate) per g, 100 g

Application

Betnovate 1/5

1

4.93

6.84

 

Application

Celestone-M

1

4.93

7.25

 

Cream 500 micrograms (as dipropionate) per
g, 15 g

Application

Diprosone

1

3.65

5.92

 

Cream 500 micrograms (as valerate) per g, 15 g

Application

Betnovate 1/2

1

2.50

4.88

 

Ointment 500 micrograms (as dipropionate) per g, 15 g

Application

Diprosone

1

3.65

5.92

 

5.            Schedule 1 - entry for Codeine with paracetamol

 

Omit

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Panadeine Forte

20

2.50

4.45

 

Insert

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Panadeine Forte

20

2.50

5.40

 

6.            Schedule 1 - entry for Gliclazide

 

Omit

Gliclazide

Tablet 60 mg (modified release)

Oral

Diamicron 60mg MR

60

4.48

9.19

 

Insert

Gliclazide

Tablet 60 mg (modified release)

Oral

Diamicron 60mg MR

60

4.48

11.64

 

 

7.            Schedule 1 - entry for Irbesartan

 

Omit

Irbesartan

Tablet 75 mg

Oral

Avapro

30

2.50

4.96

Irbesartan

Tablet 75 mg

Oral

Karvea

30

2.50

4.96

Irbesartan

Tablet 150 mg

Oral

Avapro

30

2.50

4.97

Irbesartan

Tablet 150 mg

Oral

Karvea

30

2.50

4.97

Irbesartan

Tablet 300 mg

Oral

Avapro

30

3.50

5.97

Irbesartan

Tablet 300 mg

Oral

Karvea

30

3.50

5.97

 

Insert

Irbesartan

Tablet 75 mg

Oral

Avapro

30

2.50

5.40

Irbesartan

Tablet 75 mg

Oral

Karvea

30

2.50

5.40

Irbesartan

Tablet 150 mg

Oral

Avapro

30

2.50

5.40

Irbesartan

Tablet 150 mg

Oral

Karvea

30

2.50

5.40

Irbesartan

Tablet 300 mg

Oral

Avapro

30

3.50

6.40

Irbesartan

Tablet 300 mg

Oral

Karvea

30

3.50

6.40

8.            Schedule 1 - entry for Irbesartan with hydrochlorothiazide

 

Omit

Irbesartan with hydrochlorothiazide

Tablet 150 mg-12.5 mg

Oral

Avapro HCT 150/12.5

30

2.50

4.97

Irbesartan with hydrochlorothiazide

Tablet 150 mg-12.5 mg

Oral

Karvezide 150/12.5

30

2.50

4.97

Irbesartan with hydrochlorothiazide

Tablet 300 mg-12.5 mg

Oral

Avapro HCT 300/12.5

30

3.60

6.06

Irbesartan with hydrochlorothiazide

Tablet 300 mg-12.5 mg

Oral

Karvezide 300/12.5

30

3.60

6.06

Irbesartan with hydrochlorothiazide

Tablet 300 mg-25 mg

Oral

Avapro HCT 300/25

30

3.92

6.38

Irbesartan with hydrochlorothiazide

Tablet 300 mg-25 mg

Oral

Karvezide 300/25

30

3.92

6.38

 

Insert

Irbesartan with hydrochlorothiazide

Tablet 150 mg-12.5 mg

Oral

Avapro HCT 150/12.5

30

2.50

5.40

Irbesartan with hydrochlorothiazide

Tablet 150 mg-12.5 mg

Oral

Karvezide 150/12.5

30

2.50

5.40

Irbesartan with hydrochlorothiazide

Tablet 300 mg-12.5 mg

Oral

Avapro HCT 300/12.5

30

3.60

6.50

Irbesartan with hydrochlorothiazide

Tablet 300 mg-12.5 mg

Oral

Karvezide 300/12.5

30

3.60

6.50

Irbesartan with hydrochlorothiazide

Tablet 300 mg-25 mg

Oral

Avapro HCT 300/25

30

3.92

6.82

Irbesartan with hydrochlorothiazide

Tablet 300 mg-25 mg

Oral

Karvezide 300/25

30

3.92

6.82

 

 

9.            Schedule 1 - entry for Ketoprofen

 

Omit

Ketoprofen

Capsule 200 mg (sustained release)

Oral

Orudis SR 200

28

7.03

8.25

 

Insert

Ketoprofen

Capsule 200 mg (sustained release)

Oral

Orudis SR 200

28

7.03

9.71

 

 

10.         Schedule 1 - entry for Lansoprazole

 

Omit

Lansoprazole

Tablet 15 mg (orally disintegrating)

Oral

Zoton FasTabs

28

3.42

7.89

 

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

4.48

8.30

 

Insert

Lansoprazole

Tablet 15 mg (orally disintegrating)

Oral

Zoton FasTabs

28

3.42

7.89

 

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

4.48

9.35

 

 

11.         Schedule 1 - entry for Levonorgestrel with ethinylestradiol

 

Omit

Levonorgestrel with ethinylestradiol

Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets

Oral

Levlen ED

4

4.75

9.37

 

Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets

Oral

Triphasil 28

4

7.18

19.27

 

Insert

Levonorgestrel with ethinylestradiol

Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets

Oral

Levlen ED

4

4.75

9.37

 

 

12.         Schedule 1 - entry for Oxycodone

Omit

Oxycodone

Tablet containing oxycodone hydrochloride 5 mg

Oral

Endone

20

2.50

4.50

 

Insert

Oxycodone

Tablet containing oxycodone hydrochloride 5 mg

Oral

Endone

10

1.25

2.25

 

 

Oral

Endone

20

2.50

4.50

 

 

 

13.         Schedule 1 - entry for Perindopril with indapamide

Omit

Perindopril with indapamide

Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 m

Oral

Coversyl Plus LD 2.5mg/0.625mg

30

2.50

9.83

 

Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg

Oral

Coversyl Plus 5mg/1.25mg

30

3.50

10.14

 

Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg

Oral

Perindo Combi 4/1.25

30

3.50

6.23

 

Insert

Perindopril with indapamide

Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 m

Oral

Coversyl Plus LD 2.5mg/0.625mg

30

2.50

9.83

 

Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg

Oral

Coversyl Plus 5mg/1.25mg

30

3.50

10.14

 

 

14.         Schedule 1 - entry for Pravastatin

Omit

Pravastatin

Tablet containing pravastatin sodium 10 mg

Oral

Cholstat 10

30

2.50

5.25

 

 

Oral

Pravachol

30

2.50

6.29

 

Tablet containing pravastatin sodium 20 mg

Oral

Pravachol

30

2.77

6.57

 

Tablet containing pravastatin sodium 40 mg

Oral

Pravachol

30

3.53

7.33

 

Tablet containing pravastatin sodium 80 mg

Oral

Pravachol

30

5.43

9.38

 

Insert

Pravastatin

Tablet containing pravastatin sodium 10 mg

Oral

Cholstat 10

30

2.50

5.25

 

 

Oral

Pravachol

30

2.50

7.12

 

Tablet containing pravastatin sodium 20 mg

Oral

Pravachol

30

2.77

7.40

 

Tablet containing pravastatin sodium 40 mg

Oral

Pravachol

30

3.53

8.17

 

Tablet containing pravastatin sodium 80 mg

Oral

Pravachol

30

5.43

10.22

 

 

15.         Schedule 1 - omit entry for Ranitidine

Omit

Ranitidine

Tablet 150 mg (as hydrochloride

Oral

Zantac

60

3.50

5.06

 

Tablet 300 mg (as hydrochloride)

Oral

Zantac

30

3.50

5.06

16.         Schedule 1 - entry for Rasagiline

Omit

Rasagiline

Tablet 1 mg (as mesilate)

Oral

Azilect

30

39.62

42.47

 

Insert

Rasagiline

Tablet 1 mg (as mesilate)

Oral

Azilect

30

39.62

42.97